Patents by Inventor Bradley M. LUNDE

Bradley M. LUNDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEINS BINDING NKG2D, CD16 AND A TUMOR-ASSOCIATED ANTIGEN
    Publication number: 20220153848
    Abstract: Multi-specific binding proteins that bind NKG2D receptor, CD 16, and a tumor-associated antigen selected from c-MET, KIT, F3, IGF1R, Lewis Y, MUC13, MUC4, MCAM, LRRC32, sialyl-Tn, gpA33, GD3, GM2, EPHA3, TNFRSF10A, TNFSF11, CD74, and PMEL are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
    Type: Application
    Filed: August 8, 2019
    Publication date: May 19, 2022
    Inventors: Gregory P. CHANG, Ann F. CHEUNG, Jinyan DU, Daniel FALLON, Asya GRINBERG, William HANEY, Bradley M. LUNDE, Steven O'NEIL, Bianka PRINZ, Ronnie WEI
  • PROTEINS BINDING CD33, NKG2D AND CD16
    Publication number: 20210130471
    Abstract: Multi-specific binding proteins that bind CD33, the NKG2D receptor, and CD 16 are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
    Type: Application
    Filed: February 20, 2018
    Publication date: May 6, 2021
    Inventors: Gregory P. CHANG, Ann F. CHEUNG, William HANEY, Bradley M. LUNDE, Bianka PRINZ
  • PROTEINS BINDING NKG2D, CD16 AND FLT3
    Publication number: 20200165344
    Abstract: Multi-specific binding proteins that bind NKG2D receptor, CD 16, and a tumor-associated antigen FLT3 are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
    Type: Application
    Filed: July 31, 2018
    Publication date: May 28, 2020
    Inventors: Gregory P. CHANG, Ann F. CHEUNG, William HANEY, Bradley M. LUNDE, Bianka PRINZ
  • PROTEINS BINDING BCMA, NKG2D AND CD16
    Publication number: 20190375838
    Abstract: Multi-specific binding proteins that bind BCMA, the NKG2D receptor, and CD 16 are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.
    Type: Application
    Filed: February 9, 2018
    Publication date: December 12, 2019
    Inventors: Gregory P. CHANG, Ann F. CHEUNG, William HANEY, Bradley M. LUNDE, Bianka PRINZ